These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6760532)

  • 41. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N; Kaushik P; Rai A
    Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Field evaluation of the immunogenic strength of anti-rabies vaccines for human use in Spain].
    Lozano J; Vos Saus R; Cabrero C; Ruiz-Falcó F
    Rev Sanid Hig Publica (Madr); 1979; 53(1-2):169-88. PubMed ID: 262679
    [No Abstract]   [Full Text] [Related]  

  • 45. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
    Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
    Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Modifications to a method of controlling the immunogenic activity of rabies vaccines].
    Tsetlin EM; Romanova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):84-8. PubMed ID: 8059580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value determination of rabies vaccine according to Hempt in the Habel- and Plantar test according to Krause].
    Glathe H
    Z Gesamte Hyg; 1966 Jun; 12(6):449-54. PubMed ID: 5964479
    [No Abstract]   [Full Text] [Related]  

  • 48. [Potency testing of inactivated rabies vaccines. Problems posed by the use of the Habel test].
    Aubert MF; Andral L
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):341-9. PubMed ID: 318239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunogenicity of antirabies vaccines].
    Albrycht H; Wysokińska T
    Med Dosw Mikrobiol; 1972; 24(2):141-51. PubMed ID: 5064355
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anti-rabies vaccine with aluminum hydroxide and tests for controlling its efficiency].
    Da Silva RA; Cunha RG
    Rev Bras Biol; 1973 Mar; 33(1):127-34. PubMed ID: 4805126
    [No Abstract]   [Full Text] [Related]  

  • 51. [Rabies vaccine in Czechoslovakia. II. Vaccines from duck embryos and Selim's vaccine from tissue cultures].
    Zácková Z; Dousková N; Slonim D
    Cesk Epidemiol Mikrobiol Imunol; 1984 Mar; 33(2):76-82. PubMed ID: 6232011
    [No Abstract]   [Full Text] [Related]  

  • 52. [Proposed general method of controlling the activity of brucella vaccines].
    Plommet M; Bosseray N
    Dev Biol Stand; 1984; 56():247-55. PubMed ID: 6489616
    [No Abstract]   [Full Text] [Related]  

  • 53. Laboratory techniques in rabies. Modified Habel test for potency.
    Habel K
    Monogr Ser World Health Organ; 1966; 23():144. PubMed ID: 4960444
    [No Abstract]   [Full Text] [Related]  

  • 54. Laboratory techniques in rabies. Habel test for potency.
    Habel K
    Monogr Ser World Health Organ; 1966; 23():140-3. PubMed ID: 4960443
    [No Abstract]   [Full Text] [Related]  

  • 55. Laboratory techniques in rabies: the NIH test for potency.
    Seligmann EB
    Monogr Ser World Health Organ; 1973; (23):279-86. PubMed ID: 4219494
    [No Abstract]   [Full Text] [Related]  

  • 56. Joint WHO/IABS symposium standardization of rabies vaccines for human use produced in tissue cultures (Rabies III): Summary and conclusions.
    Dev Biol Stand; 1978; 40():273-8. PubMed ID: 355020
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heat stability of a lyophilized inactivated anti-rabies-vaccine].
    Jaeger O; Barth R
    Zentralbl Bakteriol Orig; 1969 May; 210(1):135-9. PubMed ID: 5361074
    [No Abstract]   [Full Text] [Related]  

  • 58. [The production of rabies vaccine in suckling mice].
    López Pintado M
    Salud Publica Mex; 1974; 16(3):451-63. PubMed ID: 4453949
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of indirect plaque method for evaluation of the specific activity of antirabies vaccine].
    Mad'iarova RS; Morogova VM
    Vopr Virusol; 1974; (1):100-3. PubMed ID: 4614584
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative antigenicity of lyophilized and liquid Finnish antirabies vaccine.
    Rislakki V; Estola T
    Bull Off Int Epizoot; 1965 May; 64():703-8. PubMed ID: 5868393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.